SCM
CBST

Stux Capital Management’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Stux Capital Management’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$202K Sell
2,900
-400
-12% -$27.2K 0.03% 441
2014
Q1 		$241K Sell
3,300
-300
-8% -$22.4K 0.03% 390
2013
Q4 		$248K Hold
3,600
– – 0.03% 372
2013
Q3 		$229K Buy
+3,600
New +$218K 0.03% 341

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Stux Capital Management's CBST Position: Q2 2014 in Review

Stux Capital Management reduced its CUBIST PHARMACEUTICALS INC (CBST) stake by 12% in Q2 2014, selling an estimated $27.2K and leaving 2,900 shares worth $202K. The position accounts for 0.03% of the portfolio, ranked #441.

Stux Capital Management first reported a position in CBST in Q3 2013 and has held it in 4 quarters since. The position peaked at $248K in Q4 2013. 270 funds tracked by Wall St. Rank hold CBST as of Q2 2014.

  • Stux Capital Management held 2,900 shares of CUBIST PHARMACEUTICALS INC worth $202K as of Q2 2014.
  • Stux Capital Management sold 400 CUBIST PHARMACEUTICALS INC shares in Q2 2014, an estimated $27.2K.
  • CUBIST PHARMACEUTICALS INC made up 0.03% of Stux Capital Management's portfolio in Q2 2014, its #441 holding.
  • Stux Capital Management first reported a position in CUBIST PHARMACEUTICALS INC in Q3 2013 and has held it in 4 quarters since.
  • Stux Capital Management's CUBIST PHARMACEUTICALS INC position peaked at $248K in Q4 2013.
  • 270 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q2 2014.

Based on Stux Capital Management's 13F filing for Q2 2014, filed 14 Jul 2014.